GAIN THERAPEUTICS INC

Gain Therapeutics Presents Preclinical Data on its Structurally Targeted Allosteric Regulators in GBA1 Gaucher Disease at the WORLDSymposium 2022

08 Feb 2022 08:00:01 By Nasdaq GlobeNewswire

Gain Therapeutics Outlines Key Objectives for 2022 Following its Inaugural R&D Day

04 Feb 2022 12:06:54 By Nasdaq GlobeNewswire

Gain Therapeutics Announces Additional Details on its February 4th Virtual R&D Day

31 Jan 2022 16:05:00 By Nasdaq GlobeNewswire

Gain Therapeutics Announces R&D Day Event and Participation in Upcoming Conferences

18 Jan 2022 08:00:02 By Nasdaq GlobeNewswire

Gain Therapeutics to Participate at the H.C. Wainwright Bioconnect Virtual Conference

06 Jan 2022 16:05:00 By Nasdaq GlobeNewswire

Gain Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

28 Dec 2021 16:05:00 By Nasdaq GlobeNewswire

Gain Therapeutics Progresses Krabbe Disease Program and Provides Scientific Update

07 Dec 2021 08:00:02 By Nasdaq GlobeNewswire

Gain Therapeutics to Participate at the Imagine AI + Healthcare Investor Summit

01 Dec 2021 16:07:42 By Nasdaq GlobeNewswire

Gain Therapeutics, Inc. Reports Third Quarter 2021 Financial Results and Business Update

12 Nov 2021 07:00:02 By Nasdaq GlobeNewswire

Gain Therapeutics Presents Parkinson’s Disease Preclinical Study Results at Society for Neuroscience Annual Meeting

11 Nov 2021 11:00:00 By Nasdaq GlobeNewswire

Gain Therapeutics, Inc. Announces Breakthrough Pre-Clinical Data of Novel Small Molecules for the Treatment of Parkinson’s Disease and Gaucher Disease

10 Nov 2021 11:00:00 By Nasdaq GlobeNewswire

Gain Therapeutics to Present at the 12th Annual Jefferies London Healthcare Conference

04 Nov 2021 16:05:00 By Nasdaq GlobeNewswire

Gain Therapeutics to Present at Upcoming Medical Conferences

28 Oct 2021 08:00:03 By Nasdaq GlobeNewswire

Gain Therapeutics, Inc. Announces Appointment of Five Members to its Newly Formed Scientific Advisory Board (SAB)

26 Oct 2021 08:00:02 By Nasdaq GlobeNewswire

Gain Therapeutics Appoints Matthias Alder as Chief Operating Officer

19 Oct 2021 08:00:01 By Nasdaq GlobeNewswire

Gain Therapeutics to Present at the Cantor Virtual Global Healthcare Conference

23 Sep 2021 08:00:01 By Nasdaq GlobeNewswire

Gain Therapeutics to Present at the Oppenheimer Fall Healthcare Life Sciences & MedTech Summit

17 Sep 2021 08:00:00 By Nasdaq GlobeNewswire

Gain Therapeutics to Present at 2021 International Virtual GM1 Community Conference

09 Sep 2021 16:20:04 By Nasdaq GlobeNewswire

Gain Therapeutics, Inc. Announces Positive Topline Data in Patient-derived iPSC Study Evaluating STAR Compounds as a Treatment for Gaucher and Parkinson’s Disease

08 Sep 2021 09:08:54 By Nasdaq GlobeNewswire

Gain Therapeutics, Inc. Announces Positive Topline Data in Patient-derived iPSC Study Evaluating STAR Compounds as a Treatment for Gaucher and Parkinson’s Disease

08 Sep 2021 07:29:00 By Nasdaq GlobeNewswire